Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences PCR & Next-Gen Sequencing

Robin Coope's Biography

Robin Coope, Group Leader and CoDirector, British Columbia Cancer Agency Genome Sciences Centre

Robin Coope is the Instrumentation Group Leader at the BC Cancer Agency's Genome Sciences Centre and has been in the genomics field since 2000. In this position Dr. Coope is responsible for evaluating new instrumentation as well as designing de-novo solutions. He holds a BASc and MASc in Engineering Physics and a PhD in Physics from the University of British Columbia. At the GSC, Dr. Coope led several large scale automation efforts including mechanizing a large scale genomic mapping pipeline to characterize large scale rearrangements in follicular lymphoma genomes and more recently, leading the development of the first 96 channel size selection robot for NGS sample preparation. The latter has recently been licensed to a spinoff company, Coastal Genomics, who are commercializing it. As co-director of the Genome British Columbia Technology Development Platform, Dr. Coope has also been involved in several biomedical device development projects, including a novel implant for minimally invasive fixation of pelvic fractures, which has also been recently been licensed. He has published on solid state physics, display research and genome and biology and technology.

Robin Coope Image

Challenges and Opportunities in Automation for NGS Sample Preparation

Wednesday, 30 April 2014 at 14:15

Add to Calendar ▼2014-04-30 14:15:002014-04-30 15:15:00Europe/LondonChallenges and Opportunities in Automation for NGS Sample

The British Columbia Cancer Agency's Genome Sciences Centre has processed about 12,500 libraries in the last 12 months, and these range from large mRNA and miRNA research sample cohorts to clinical amplicons sets and whole genomes and transcriptomes for personalized onco-genomics. This has produced a range of challenges including the need to automate difficult processes such as poly-A capture and gel based size selection, the need to handle sample sets of variable size in the same pipeline, and the ever present need for robust, fast and actionable QC. This talk will describe several of these areas where what was thought to be easy turned out to hard, and highlight some of our novel solutions automation solutions.

Add to Calendar ▼2014-04-29 00:00:002014-04-30 00:00:00Europe/LondonPCR and Next-Gen